Your browser doesn't support javascript.
loading
Observational study to predict the efficacy and optimal duration of nivolumab treatment in patients with previously treated advanced or recurrent non-small cell lung cancer.
Goto, Yasushi; Yoh, Kiyotaka; Kato, Terufumi; Hosomi, Yukio; Usui, Kazuhiro; Fukui, Tomoya; Hirano, Katsuya; Tanaka, Hiroshi; Taguri, Masataka; Kunitoh, Hideo.
Afiliação
  • Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Yoh K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
  • Hosomi Y; Department of Thoracic Oncology & Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
  • Usui K; Division of Respirology, NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, Japan.
  • Fukui T; Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
  • Hirano K; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan.
  • Tanaka H; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Niigata, Japan.
  • Taguri M; Department of Data Science, Yokohama City University Graduate School of Data Science, Yokohama, Kanagawa, Japan.
  • Kunitoh H; Department of Medical Oncology, Japanese Red Cross Medical Center, Shibuya-ku, Tokyo, Japan.
Jpn J Clin Oncol ; 53(2): 153-160, 2023 Jan 28.
Article em En | MEDLINE | ID: mdl-36300307

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article